Farmak was included in the ranking of the best enterprises according to the CSR Index 2023, which determines the sustainability of Ukrainian businesses during the war. The study was conducted…
Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…